A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 649 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Can Fertility Drugs or IVF Increase My Risk for Cancer? November 15, 2022 EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with... July 17, 2024 Talazoparib Does Not Prolong OS in BRCA1/2-mutated, HER2-negative Advanced Breast Cancer August 21, 2020 Tumors With KRAS G12C Mutation Respond to Adagrasib and Using Toripalimab... April 19, 2023 Load more HOT NEWS On legacy giving: “It allows me to give something more meaningful... New Device Could “Hear” Stiffening of Extracellular Matrix to Determine Where... FDA Approves HPV Tests That Allow for Self-Collection in a Health... Julia Louis-Dreyfus Talks About The Side Effects of Chemotherapy
